Mercury Biopharmaceutical Corporation (TPEX: 6932)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.60
+0.40 (2.63%)
Sep 10, 2024, 2:46 PM CST

Mercury Biopharmaceutical Market Cap

Mercury Biopharmaceutical has a market cap or net worth of 6.47 billion as of September 10, 2024. Its market cap has decreased by -22.27% in one year.

Market Cap
6.47B
Enterprise Value
6.24B
Revenue
5.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.60

Market Cap Chart

Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 6.47B, an increase of 26.69%. That is a compound annual growth rate of 14.77%.

History

DateMarket Cap% Change
Sep 10, 20246.47B-16.87%
Dec 29, 20237.78B94.15%
Dec 30, 20224.01B-21.50%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition